Company
Birmingham
Every investor coverage indicates participated in a round University of Alabama at Birmingham raised.
Companies University of Alabama at Birmingham acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Anupam Agarwal | Senior Vice President for Medicine and Dean of the Marnix E. Heersink School of Medicine | evtoday.com, vexev.com (Fri 7 Aug 2026), vexev.com (Thu 6 Aug 2026) |
Stories naming University of Alabama at Birmingham. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Australian medical robotics firm Vexev has raised A$8.6 million to pursue FDA clearance and US commercialisation of its VxWave robotic ultrasound platform, with backing from existing and new investors.
Also Startup Daily·This Week in Australian Startups·SmartCompany
Medical device maker Sunshine Heart reports its first two American C-Pulse patients cleared three-month follow-ups, booked initial reimbursement revenue from an Ohio trial site, and outlines coming CE Mark and FDA steps.
ASX-listed heart device maker Sunshine Heart has finished training clinicians at six US hospitals ahead of its C-Pulse feasibility trial, planned to start later in 2007.